, Rosa Di Paola 1* Supplementary Table S1 . List of reference genes evaluated in 150 subjects randomly chosen from GS2. Gene Name/ Gene Symbol Unique Assay ID actin, beta / ACTB qHsaCED0036269 aminolevulinate, delta-, synthase 1 / ALAS1 qHsaCID0009300 beta-2-microglobulin / B2M qHsaCID0015347 cyclin-dependent kinase inhibitor 1A (p21, Cip1) / CDKN1A qHsaCID0014498 glucose-6-phosphate dehydrogenase / G6PD qHsaCED0001353 glyceraldehyde-3-phosphate dehydrogenase / GAPDH qHsaCED0038674 glucuronidase, beta / GUSB qHsaCID0011706 hemoglobin, beta / HBB qHsaCED0020657 hydroxymethylbilane synthase/ HMBS qHsaCID0038839 hypoxanthine phosphoribosyltransferase 1 / HPRT1 qHsaCID0016375 heat shock protein 90kDa alpha (cytosolic), class B member 1 / HSP90AB1 qHsaCED0038850 importin 8 / IPO8 qHsaCED0005354 lactate dehydrogenase A / LDHA qHsaCED0001212 non-POU domain containing, octamer-binding / NONO qHsaCED0002050 phosphoglycerate kinase 1 / PGK1 qHsaCED0003721 processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae) / POP4 qHsaCID0015127 peptidylprolyl isomerase A (cyclophilin A) / PPIA qHsaCED0038620 peptidylprolyl isomerase H (cyclophilin H) / PPIH qHsaCID0038169 proteasome (prosome, macropain) 26S subunit, ATPase, 4 / PSMC4 qHsaCID0011519 pumilio homolog 1 (Drosophila) / PUM1 qHsaCID0010952 ribosomal protein L13a / RPL13A qHsaCED0020417 ribosomal protein L30 / RPL30 qHsaCED0038096 ribosomal protein, large, P0 / RPLP0 qHsaCED0038653 ribosomal protein S17 / RPS17 qHsaCED0041771 ribosomal protein S18 / RPS18 qHsaCED0037454 succinate dehydrogenase complex, subunit A, flavoprotein (Fp) / SDHA qHsaCED0038853 TATA box binding protein / TBP qHsaCID0007122 transferrin receptor (p90, CD71) /TFRC qHsaCID0022106 ubiquitin C / UBC qHsaCED0023867 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide / YWHAZ qHsaCID0013897
SUPPLEMENTARY INFORMATION
Unique Assay ID. This is a unique identifier that can be used to identify the assay in the literature and online at www.bio-rad.com/. 
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SUPPLEMENTARY FIGURES
Supplementary Figure S1. Distribution of w-eRPSs (Panel A) and w-sRPSs (Panel B).
Both w-sRPSs and w-eSRPs were calculated as described in Methods. Briefly: i) expression and serum data were rescaled; ii) bootstrapped multivariable linear regression analyses for each outcome were performed to obtained the regression coefficients estimates (βs) for each cytokine; iii) each raw w-RPS has been obtained as (β1×cytokine 1)+(β2×cytokine 2)+(β3×cytokine 3) and so on; iv) each final w-RPS has been obtained after rescaling the score by its SD.
Panel A shows the distribution of w-eRPSs for each IR/LGI-related cardiovascular risk factor in GS2. 
